Nature Communications

Efficacy of JAK1/2 inhibition in murine myeloproliferative neoplasms is not mediated by targeting oncogenic signaling

Blood

Defective neutrophil clearance in JAK2V617F myeloproliferative neoplasms drives myelofibrosis via immune checkpoint CD24

European Journal of Haematology

Time without transfusion reliance (TWiTR): Integrating survival quality into myelofibrosis treatment strategies based on the phase 3 SIMPLIFY-1, SIMPLIFY-2, and MOMENTUM trials

Indian Journal of Hematology and Blood Transfusion

Renal impairment in myeloproliferative neoplasms: An under-reported complication

Blood Neoplasia

Addition of navitoclax to ruxolitinib for patients with myelofibrosis with progression or suboptimal response

Blood Work

Primary myelofibrosis involving lymph nodes with the same mutational profile in bone marrow

Frontiers in Oncology

Case report: Sclerosing variant of extramedullary hematopoietic tumor primary arising in kidney, unexpected clinical and pathological presentation

Haematologica

Characterization and prognostic implication of pulmonary hypertension among patients with myeloproliferative neoplasms